cover
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kota surabaya,
Jawa timur
INDONESIA
Berkala Ilmu Kesehatan Kulit dan Kelamin
Published by Universitas Airlangga
ISSN : 19784279     EISSN : 25494082     DOI : 10.20473
Core Subject : Health, Science,
Arjuna Subject : -
Articles 12 Documents
Search results for , issue "Vol. 37 No. 3 (2025): DECEMBER" : 12 Documents clear
Characteristics of Cutaneous Lupus Erythematosus Patients in Dermatology and Venereology Outpatient Clinic Suryawati, Nyoman; Praharsini, I Gusti Ayu Agung; Elis Indira, I Gusti Ayu Agung; Darmaputra, I Gusti Nyoman
Berkala Ilmu Kesehatan Kulit dan Kelamin Vol. 37 No. 3 (2025): DECEMBER
Publisher : Faculty of Medicine, Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/bikkk.V37.3.2025.153-162

Abstract

Background: Cutaneous lupus erythematosus (CLE) is a specific skin manifestation of lupus erythematosus. This condition can be accompanied by systemic involvement that affect patient therapy and prognosis. The characteristics of CLE patients in Indonesia have not been widely reported. This study aims to determine the prevalence and characteristics of CLE patients at Dermatology and Venereology Outpatient Clinic of Allergy and Immunology Division at Ngoerah Hospital. Methods: This research used descriptive analysis with a cross-sectional design and total sampling method. Result: The total number of patients was 34, with prevalence of 6.7 cases per 1,000 patients. The majority of patients were female (85.3%), Balinese ethnicity (70.6%), unemployed (53%), with a high school/vocational high school education (56%), and risk factors of sun exposure (80.0%). Most patients had no family history of Lupus erythematosus (LE) (65.7%). The most frequent skin manifestation was chronic type CLE (28.6%). Based on The European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) score, 27 patients (77.1%) met Systemic lupus erythematosus (SLE) criteria. Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) activity, damage, and Mexican Systemic Lupus Erythematosus Disease Activity (MEX-SLEDAI) scores were 3.35±4.52, 0.88±1.96, and 7.5±5.09. Systemic therapy included methylprednisolone (47%) and hydroxychloroquine (35.2%), topical treatment included high to very high-potency steroids (67.6%), and sunscreen (14.7%). Response therapy was generally good in 68.6% of patients. Conclusion: The most common type of CLE is chronic cutaneous lupus erythematosus. Most patients improved, with the majority using systemic methylprednisolone and topical high-potency corticosteroids. Oral treatment responses tend to be good.
Measurement of Ultraviolet-B (UVB) Minimum Erythema Dosage (MED) Based on Sun Exposure as the Basis of Sunlight Phototherapy: Study of Skin Type III or IV at Various Altitudes in Indonesia Meidiyanti, Prima; Radiono, Sunardi; Stella, Maureen Miracle; Febiyanto, Novian; Arief Budiyanto
Berkala Ilmu Kesehatan Kulit dan Kelamin Vol. 37 No. 3 (2025): DECEMBER
Publisher : Faculty of Medicine, Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/bikkk.V37.3.2025.185-189

Abstract

Background: Phototherapy facilities for skin diseases are not widely available in Indonesia. No studies have yet measured the duration of sunbathing to achieve a minimal erythema dose (MED) in healthy volunteers at various altitudes. Purpose: This study calculates the duration of sunbathing to achieve the MED at various altitudes. Methods: This study was conducted in various regions of Yogyakarta, Indonesia, with latitude 7◦15’-8◦15’ S and 110◦5’-110◦4’ E, within the Yogyakarta equinox period by including three places with different altitude groups at 10:00 WIB (UTC+7). Forty-eight healthy individuals of skin type III or IV were exposed to sunlight using a photo-opaque template with 8 squares, each with 1 x 1 cm2 holes. The squares will receive an increase in exposure duration of as many as 250 seconds. Result: There was a significant difference in the mean UVB intensity between all heights (p <0.05). The average duration of sunbathing to reach MED at an altitude of 0-300 masl, > 300-600 masl, and > 600-950 masl are 22 minutes 40 seconds, 20 minutes 34 seconds, and 18 minutes 14 seconds, respectively. There is no significant difference in the duration of sunbathing between altitudes of 0-300 masl and 300-600 masl and between 300-600 masl and 600-950 masl (p> 0.05). However, there was a significant difference in the duration of sunbathing between the altitudes of 0-300 masl and 600-950 masl (p <0.05). Conclusion: A difference exists in the duration of sunbathing required to achieve MED at altitudes greater than 600 masl

Page 2 of 2 | Total Record : 12